A pilot trial of an implementation study of shared medical appointment model construction for diabetes in community-dwelling older adults

An implementation study of shared medical appointment model construction for diabetes in community-dwelling older adults: a multiphase optimization strategy based randomized controlled trial (SMART)

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2200064691

Enrollment

Unknown

Registered

2022-10-14

Start date

2022-11-01

Completion date

Unknown

Last updated

2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes

Interventions

Experimental group:Shared medical appointment diagnosis and treatment mode

Control group:Conventional diagnosis and treatment mode

Eligibility

Sex/Gender

All

Age

60 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. For settings: CHCs and THCs in Zunyi and Tongren of Guizhou province who are responsible for managing diabetes patients and willing to participate in the SMART program will be enrolled. 2. For patients: (1) Diabetes patients who meet the Chinese T2DM diagnostic criteria guidelines and are >=60 years old are the study population of the SMART project; (2) Live in the community served by the participating medical institutions; (3) Participate in basic public health services in the community, and have two consecutive Fasting blood glucose (FG) >= 7 mmol/L or postprandial blood glucose (PPG) >= 11.0 mmol/L; (4) Have basic literacy, sufficient cognitive and physical abilities; (5) Be willing to provide informed consent to participate in the study.

Exclusion criteria

Exclusion criteria: 1. Exclusion criteria for settings: None. 2. Exclusion criteria for patients: (1) Acute complications of diabetes; (2) Physical activity limitation due to complications or comorbidities during recruitment; (3) Patients who are participating in other clinical trials; (4) Patients who are considered unsuitable for this study by the researchers for other reasons.

Design outcomes

Primary

Measure	Time frame
Hemoglobin A1c;	—

Secondary

Measure	Time frame
Fasting glucose (PrePrandial Glucose);PostPrandial Glucose;Blood pressure;Lipid;Chinese Mini-Mental State Examination (C-MMSE);Centre for Epidemiologic Studies Depression Scale (CES-D);Chinese version of the Diabetes Management Self-efficacy Scale (C-DMSES);Summary of diabetes self-care activities (SDSCA);Food frequency questionnaire (FFQ);Demand-side perspective of PCC service quality (PPPC-CN);Body mass index (BMI);Waist-hip ratio (WHR);36-item short-form survey (SF-36);Brief medication questionnaire (BMQ);Readiness questionnaire;Evidence based practice capability assessment;Patient-centerd care assessment;Quality of medical care and health management assessment;	—

Measure

Time frame

Fasting glucose (PrePrandial Glucose);PostPrandial Glucose;Blood pressure;Lipid;Chinese Mini-Mental State Examination (C-MMSE);Centre for Epidemiologic Studies Depression Scale (CES-D);Chinese version of the Diabetes Management Self-efficacy Scale (C-DMSES);Summary of diabetes self-care activities (SDSCA);Food frequency questionnaire (FFQ);Demand-side perspective of PCC service quality (PPPC-CN);Body mass index (BMI);Waist-hip ratio (WHR);36-item short-form survey (SF-36);Brief medication questionnaire (BMQ);Readiness questionnaire;Evidence based practice capability assessment;Patient-centerd care assessment;Quality of medical care and health management assessment;

—

Countries

China

Contacts

Public ContactYiyuan Cai

School of Public Health and HSchool of Public Health and Health, Guizhou Medical Universityealth, Guizhou Medical University, University City, Guian New District, Guizhou Province

caiyiyuan@gmc.edu.cn+86 15329009316

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026